Hemodynamic drug interactions.
D000818:Animals; D000983:Antipyrine / Q000097:blood; D004285:Dogs; D004298:Dopamine / Q000494:pharmacology; D004347:Drug Interactions; D004790:Enzyme Induction; D005934:Glucagon / Q000494:pharmacology; D006207:Half-Life; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008012:Lidocaine / Q000097:blood; D008102:Liver Circulation / Q000187:drug effects; D008253:Macaca mulatta; D008657:Metabolic Clearance Rate; D010113:Oxyphenbutazone / Q000097:blood; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010634:Phenobarbital / Q000494:pharmacology; D011433:Propranolol / Q000097:blood / Q000494:pharmacology; D013997:Time Factors
D004364:Pharmaceutical Preparations; D005934:Glucagon; D008012:Lidocaine; D011433:Propranolol; D010113:Oxyphenbutazone; D000983:Antipyrine; D004298:Dopamine; D010634:Phenobarbital